TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 SEK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
1,007,840
|
946,961
|
1,003,226 |
| Earnings before taxes |
30,679
|
22,718
|
41,271 |
| Total assets |
487,496
|
510,609
|
491,322 |
| Current assets |
487,194
|
468,203
|
444,222 |
| Current liabilities |
286,057
|
319,871
|
266,364 |
| Equity capital |
197,333
|
171,669
|
223,394 |
| - share capital |
5,501
|
5,397
|
5,587 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
40.5%
|
33.6%
|
45.5% |
| Turnover per employee |
6,719
|
6,313
|
6,688 |
| Profit as a percentage of turnover |
3.0%
|
2.4%
|
4.1% |
| Return on assets (ROA) | |||
| Current ratio |
170.3%
|
146.4%
|
166.8% |
| Return on equity (ROE) |
15.5%
|
13.2%
|
18.5% |
| Change turnover |
42,609
|
-22,110
|
-125,595 |
| Change turnover % |
4%
|
-2%
|
-11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.